Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety.
Metselaar
H J
HJ
Department of Internal Medicine, University Hospital Rotterdam, The Netherlands.
Velzing
J
J
Rothbarth
P H
PH
Balk
A H
AH
Mochtar
B
B
Weimar
W
W
D000914:Antibodies, Viral / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000276:immunology*; D005500:Follow-Up Studies; D015488:HIV Antigens / Q000032:analysis; D006679:HIV Seropositivity / Q000209:etiology; D016027:Heart Transplantation; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006801:Humans; D007106:Immune Sera / Q000009:adverse effects; D007116:Immunization, Passive / Q000009:adverse effects; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; D008099:Liver / Q000201:enzymology; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control
D000914:Antibodies, Viral; D015488:HIV Antigens; D006514:Hepatitis B Surface Antigens; D007106:Immune Sera; D007136:Immunoglobulins; D016756:Immunoglobulins, Intravenous; C045781:cytomegalovirus-specific hyperimmune globulin